(APLS) Apellis Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Apellis Pharmaceuticals | (APLS) share price targets
Complete technical analysis of Apellis Pharmaceuticals (APLS) by charts plus indicators, forecast predictions and share price targets for Apellis Pharmaceuticals (APLS)
Apellis Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Apellis Pharmaceuticals is 2333490
Date | Daily Closing Price | Open | High | Low | Volume |
10 Fri May 2024 | 41.99 | 42.86 | 43.06 | 41.35 | 0.42 times |
09 Thu May 2024 | 42.52 | 42.73 | 43.00 | 41.71 | 0.454 times |
08 Wed May 2024 | 42.30 | 44.12 | 44.12 | 41.57 | 0.926 times |
07 Tue May 2024 | 43.90 | 45.10 | 47.60 | 41.75 | 1.937 times |
06 Mon May 2024 | 48.81 | 47.32 | 49.06 | 47.18 | 0.793 times |
03 Fri May 2024 | 47.46 | 48.46 | 48.76 | 47.22 | 0.474 times |
02 Thu May 2024 | 47.49 | 46.62 | 47.74 | 46.10 | 0.437 times |
01 Wed May 2024 | 46.05 | 44.75 | 47.23 | 44.49 | 1 times |
30 Tue Apr 2024 | 44.19 | 46.60 | 46.85 | 38.22 | 2.858 times |
29 Mon Apr 2024 | 47.84 | 48.98 | 49.38 | 47.56 | 0.6 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 41, for a target of 44.4 or 47.15
Share price targets for Apellis Pharmaceuticals (APLS)
Target Type | Value |
Downside Target | 38.22 |
Downside Target | 41.35 |
Upside Target | 46.40 |
Upside Target | 49.06 |
Upside Target | 53.06 |
Upside Target | 57.85 |
Upside Target | 58.57 |
Upside Target | 59.91 |
Upside Target | 60.52 |
Upside Target | 66.00 |
Upside Target | 71.90 |
Upside Target | 73.80 |
Intraday share price targets for Apellis Pharmaceuticals (APLS)
Target Type | Value |
Downside Intraday Target | 39.21 |
Downside Intraday Target | 36.42 |
Upside Intraday Target | 46.92 |
Upside Intraday Target | 51.84 |
Upside Intraday Target | 44.13 |
Weekly technical analysis of Apellis Pharmaceuticals (APLS)
Date | Weekly Closing Price | Open | High | Low | Volume |
10 Fri May 2024 | 41.99 | 47.32 | 49.06 | 41.35 | 0.844 times |
03 Fri May 2024 | 47.46 | 48.98 | 49.38 | 38.22 | 2.257 times |
26 Fri Apr 2024 | 49.86 | 48.08 | 50.98 | 46.63 | 0.659 times |
19 Fri Apr 2024 | 47.53 | 51.76 | 53.06 | 46.40 | 1.533 times |
12 Fri Apr 2024 | 51.79 | 55.99 | 57.85 | 50.07 | 1.178 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Apellis Pharmaceuticals (APLS)
Date | Monthly Closing Price | Open | High | Low | Volume |
10 Fri May 2024 | 41.99 | 44.75 | 49.06 | 41.35 | 0.467 times |
30 Tue Apr 2024 | 44.19 | 58.66 | 59.91 | 38.22 | 1.259 times |
28 Thu Mar 2024 | 58.78 | 62.86 | 66.00 | 53.19 | 0.862 times |
29 Thu Feb 2024 | 61.97 | 63.45 | 71.90 | 60.52 | 0.698 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Apellis Pharmaceuticals (APLS)
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Apellis Pharmaceuticals in short term and the sell signal is strong.
Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Apellis Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 44.87 and Apellis Pharmaceuticals (APLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Apellis Pharmaceuticals ( (APLS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Apellis Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Apellis Pharmaceuticals in short term and the sell signal is strong.
Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Apellis Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Apellis Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 44.87 and Apellis Pharmaceuticals (APLS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Apellis Pharmaceuticals (APLS) stock. Volume based technical analysis of Apellis Pharmaceuticals (APLS) stock is negative.
Apellis Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.